Actelion taps DKSH to break into Asia

Market-access contractor DKSH has signed a deal with Actelion Pharmaceuticals to help the company bolster its position in Asia. Under the agreement, DKSH will handle regulatory, distribution and logistics for Actelion in Hong Kong, Malaysia and Singapore, working to get the Swiss drugmaker's hypertension treatment Tracleer to physicians in each territory. DKSH has similar relationships with Roche ($RHHBY), Bristol-Myers Squibb ($BMY), Sanofi ($SNY), Bayer and others. More

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

Charles River partners with PathoQuest to offer clients NGS solutions for biologics viral contamination testing and cell-line genetic characterization.